[1] |
Corté H, Manceau G, Blons H, et al. MicroRNA and colorectal cancer[J]. Dig Liver Disc,2012,44(3):195-200.
|
[2] |
Meng W, McElroy JP, Volinia S, et al. Comparison of microRNA deep sequencing of matched formalin-fixed paraffin-embedded and fresh frozen cancer tissues[J]. PloS One,2013,8(5):e64393.
|
[3] |
Mao Y, Chen H, Lin Y, et al. microRNA-330 inhibits cell motility by downregulating Sp1 in prostate cancer cells[J]. Oncol Rep,2013,30(1):327-33.
|
[4] |
Dong Y, Wu WK, Wu CW, et al. MicroRNA dysregulation in colorectal cancer: a clinical perspective[J]. Br J Cancer,2011,104 (6) :893-8.
|
[5] |
Aslam MI, Patel M, Singh B, et al. MicroRNA manipulation in colorectal cancer cells: from laboratory to clinical application[J]. J Transl Med,2012,10:128.
|
[6] |
Schee K, Fodstad ?, Flatmark K. MicroRNAs as biomarkers in colorectal cancer[J]. Am J Pathol,2010,177(4):1592-9.
|
[7] |
Mitchell PS, Parkin RK, Kroh EM, et al. Circulating microRNAs as stable blood-based markers for cancer detection[J]. Proc Natl Acad Sci U S A,2008,105(30):10513-8.
|
[8] |
Zen K, Zhang CY. Circulating microRNAs: a novel class of biomarkers to diagnose and monitor human cancers[J]. Med Res Rev,2012,32(2):326-48.
|
[9] |
Ng EK, Chong WW, Jin H, et al. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening[J]. Gut,2009,58(10):1375-81.
|
[10] |
Huang Z, Huang D, Ni S, et al. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer[J]. Int J Cancer,2010,127(1):118-26.
|
[11] |
Chen X, Ba Y, Ma L, et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases[J]. Cell Res,2008,18(10):997-1006.
|
[12] |
Wang Q, Huang Z, Ni S, et al. Plasma miR-601 and miR-760 are novel biomarkers for the early detection of colorectal cancer[J]. PLoS One,2012,7(9):e44398.
|
[13] |
Luo X, Stock C, Burwinkel B, et al. Identification and evaluation of plasma microRNAs for early detection of colorectal cancer[J]. PLoS One,2013,8(5):e62880.
|
[14] |
Lieberman DA. Clinical practice. Screening for colorectal cancer[J]. N Engl J Med,2009,361(12):1179-87.
|
[15] |
Sali L, Grazzini G, Carozzi F, et al. Screening for colorectal cancer with FOBT, virtual colonoscopy and optical colonoscopy: study protocol for a randomized controlled trial in the Florence district (SAVE study)[J]. Trials,2013,14:74.
|
[16] |
Link A, Balaguer F, Shen Y, et al. Fecal microRNAs as novel biomarkers for colon cancer screening[J]. Cancer Epidemiol Biomarkers Prev,2010,19(7):1766-74.
|
[17] |
Kunte DP, DelaCruz M, Wali RK, et al. Dysregulation of microRNAs in colonic field carcinogenesis: implications for screening[J]. PLoS One,2012,7(9):e45591.
|
[18] |
Ahmed FE, Jeffries CD, Vos PW, et al. Diagnostic microRNA markers for screening sporadic human colon cancer and active ulcerative colitis in stool and tissue[J]. Cancer Genomics Proteomics, 20 09,6(5):281-95.
|
[19] |
Koga Y, Yasunaga M, Takahashi A, et al. MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening[J]. Cancer Prev Res (Phila),2010,3(11): 14 35-42.
|
[20] |
Ahlquist DA. Molecular detection of colorectal neoplasia[J]. Gastroenterology,2010,138(6):2127-39.
|
[21] |
Slaby O, Svoboda M, Fabian P, et al. Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer[J]. Oncology,2007, 72 (5-6):397-402.
|
[22] |
Schetter AJ, Leung SY, Sohn JJ, et al. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma[J]. JAMA,2008,299(4):425-36.
|
[23] |
Kulda V, Pesta M, Topolcan O, et al. Relevance of miR-21 and miR-143 expression in tissue samples of colorectal carcinoma and its liver metastases[J]. Cancer Genet Cytogenet,2010,200(2):154- 60.
|
[24] |
Bandrés E, Cubedo E, Agirre X, et al. Identification by Realtime PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues[J]. Mol Cancer,2006,5:29.
|
[25] |
Wang CJ, Zhou ZG, Wang L, et al. Clinicopathological significance of microRNA-31, -143 and -145 expression in colorectal cancer[J]. Dis Markers,2009,26(1):27-34.
|
[26] |
Lanza G, Ferracin M, Gafà R, et al. mRNA/microRNA gene expression profile in microsatellite unstable colorectal cancer[J]. Mol Cancer,2007,6:54.
|
[27] |
Schepeler T, Reinert JT, Ostenfeld MS, et al. Diagnostic and prognostic microRNAs in stage Ⅱ colon cancer[J]. Cancer Res,2008,68(15):6416-24.
|
[28] |
Earle JS, Luthra R, Romans A, et al. Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma[J]. J Mol Diagn,2010,12(4):433-40.
|
[29] |
Yoshida M, Goto M, Kii T, et al. Retrospective study as firstline chemotherapy combined anti-VEGF antibody with fluoropyrimidine for frail patients with unresectable or metastatic colorectal cancer [J]. Digestion,2013,87(1):59-64.
|
[30] |
Nakajima G, Hayashi K, Xi Y, et al. Non-coding MicroRNAs hsalet- 7g and hsa-miR-181b are associated with chemoresponse to S-1 in colon cancer[J]. Cancer Genomics Proteomics,2006,3(5):317-24.
|
[31] |
Song B, Wang Y, Titmus MA, et al. Molecular mechanism of chemoresistance by miR-215 in osteosarcoma and colon cancer cells[J]. Mol Cancer,2010,9:96.
|
[32] |
Ragusa M, Majorana A, Statello L, et al. Specific alterations of microRNA transcriptome and global network structure in colorectal carcinoma after cetuximab treatment[J]. Mol Cancer Ther,2010,9(12):3396-409.
|
[33] |
Svoboda M, Izakovicova Holla L, Sefr R, et al. Micro-RNAs miR125b and miR137 are frequently upregulated in response to capecitabine chemoradiotherapy of rectal cancer[J]. Int J Oncol,2008,33(3):541-7.
|
[34] |
Dai J, Gu J, Huang M, et al. GWAS-identified colorectal cancer susceptibility loci associated with clinical outcomes[J]. Carcinoge nesis,2012,33(7):1327-31.
|
[35] |
Landi D, Gemignani F, Naccarati A, et al. Polymorphisms within micro-RNA-binding sites and risk of sporadic colorectal cancer[J]. Carcinogenesis,2008,29(3):579-84.
|
[36] |
Lee HC, Kim JG, Chae YS, et al. Prognostic impact of microRNArelated gene polymorphisms on survival of patients with colorectal cancer[J]. J Cancer Res Clin Oncol,2010,136(7):1073-8.
|
[37] |
Yang R, Frank B, Hemminki K, et al. SNPs in ultraconserved elements and familial breast cancer risk[J]. Carcinogenesis,2008, 29 (2):351-5.
|
[38] |
Wojcik SE, Rossi S, Shimizu M, et al. Non-codingRNA sequence variations in human chronic lymphocytic leukemia and colorectal cancer[J]. Carcinogenesis,2010,31(2):208-5.
|